New hope for tough blood cancers: experimental drug targets Treatment-Resistant leukemia
NCT ID NCT07221500
Summary
This study is testing an experimental oral drug called NX-5948 for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has returned or stopped responding to standard treatments. The drug works differently than previous medications by completely removing a key cancer-driving protein. Researchers want to see if this approach helps control the cancer in people who have already tried and failed two other types of targeted therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL LYMPHOCYTIC LYMPHOMA (SLL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AUSL della Romagna UO Ematologia
RECRUITINGRavenna, 48121, Italy
-
Aidport Sp. z o.o.
RECRUITINGSkorzewo, 60-185, Poland
-
CHU de Nantes
RECRUITINGNantes, 44000, France
-
Colorado Blood Institute
RECRUITINGDenver, Colorado, 80218, United States
-
Florida Cancer Specialists
RECRUITINGSarasota, Florida, 34232, United States
-
Maryland Oncology Hematology
RECRUITINGSilver Spring, Maryland, 20904, United States
-
Novant Health Cancer Institute
RECRUITINGWinston-Salem, North Carolina, 27103, United States
-
Oncology Hematology Care
RECRUITINGFairfield, Ohio, 45014, United States
-
Oxford University Hospitals NHS Foundation Trust
RECRUITINGHeadington, Oxford, OX3 9D, United Kingdom
-
Pratia Hematologia Sp. z o.o.
RECRUITINGKatowice, 40-519, Poland
-
Pratia S.A.
RECRUITINGKrakow, 30-225, Poland
-
Pratia Warszawa / Pratia MTZ
RECRUITINGWarsaw, 02-172, Poland
-
SCRI Oncology Partners
RECRUITINGNashville, Tennessee, 37203, United States
-
Texas Oncology - Center South
RECRUITINGAustin, Texas, 78705, United States
-
The Christie NHS Foundation Trust
RECRUITINGManchester, M20 4BX, United Kingdom
-
The Royal Marsden NHS Foundation Trust
RECRUITINGLondon, SW3 6JJ, United Kingdom
-
University of Cincinnati
RECRUITINGCincinnati, Ohio, 45221, United States
-
Virginia Cancer Specialists, PC
RECRUITINGFairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.